Publication | Closed Access

A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer

Surgical OncologyWeekly Docetaxel/oxaliplatinGastrointestinal OncologyAdvanced Gastric CancerMedicineWeekly Docetaxel/cisplatinSurgeryCancer TreatmentOncologyRadiation Oncology